News

PELONews: MyBio Ltd. Our Exclusive Distributor of Cellovations Products in UK and Ireland

We are glad to announce that MyBio Ltd. will now be our official distributor in UK and Ireland, with over 80 years of expertise as a regional laboratory supplier.

Advancing Blood-Brain Barrier (BBB) Research: Tools and Insights from PELOBiotech

PELOBiotech offers a comprehensive range of solutions for BBB research, including high-quality primary cells, growth media, and advanced platforms like midifluidic systems and 3D hydrogels.

PELOPaper: Blood-Brain Barrier Disruption in Autoimmune Encephalitis

A recent dissertation from Charit Universit tsmedizin Berlin by Lucie Yuanting Li explores the role of autoantibodies in autoimmune encephalitis, provides insights into mechanisms that disrupt the blood-brain barrier (BBB).

Meet us at...IGLD Symposium 2025 In Frankfurt

PELOBiotech is attending, IGLD symposium from 07 - 09 March 2025 , in Frankfurt. Join us and meet our CEO Dr. Peter Frost, our Marketing head Christiane B chsel and Sales Representative Magdalena Meier at the booth. Also you can schedule face-to-face interaction with our CEO Dr. Peter Frost and team.

PELOPaper: Study of Tumor-Derived Extracellular Vesicles & BBB Disruption

Study published in Biochimica et Biophysica Acta (BBA) - Advances explores how tumor-derived extracellular vesicles (EVs) containing Valosin-Containing Protein (VCP) impact the blood-brain barrier (BBB).  

Meet us at... Elrig Forum 2025 in Darmstadt

PELOBiotech is attending The ELRIG Forum on March 13, 2025 at the Science and Congress center "darmstadtium" in Darmstadt. Schedule your on-site meeting with our CEO Dr. Peter Frost , at our booth.